Fluphenazine IM Injection bulk supplier for pharma manufacturers

Fluphenazine Im Injection 25 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Long-Acting Intramuscular Injection

Available Strengths: 25 mg/mL

Reference Brands: Prolixin Decanoate(US); Fluphenazine Decanoate(EU)

Fluphenazine IM injection is a typical antipsychotic that works by blocking dopamine D2 receptors in the brain, helping to reduce psychotic symptoms like hallucinations, delusions, and agitation. It is primarily used to treat schizophrenia and other chronic psychoses, especially in patients with poor medication adherence.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Fluphenazine IM injection, available in both short-acting and long-acting (decanoate) formulations, is FDA-approved in the United States for the treatment of chronic schizophrenia. In the EU, it is approved in select markets under national procedures. Regulatory submissions must meet GMP standards, ensure accurate dosing for depot formulations, and include safety data addressing extrapyramidal symptoms and neuroleptic malignant syndrome. EU applications must align with local pharmacovigilance requirements and psychiatric labeling standards. For global buyers seeking dossier-ready Fluphenazine IM injections and to explore other dosage forms and suppliers, visit Pharmatradz.com — your reliable B2B pharma sourcing platform.

Fluphenazine Im Injection — third party manufacturing & bulk supply

Fluphenazine Im Injection 25 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Fluphenazine Im Injection is supplied as Long-Acting Intramuscular Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Fluphenazine Im Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Fluphenazine Im Injection →

Back to Listing

Frequently Asked Questions

Fluphenazine IM Injection is listed as Long-Acting Intramuscular Injection in 25 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Fluphenazine IM Injection is referenced against Prolixin Decanoate(US); Fluphenazine Decanoate(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.